J Lange

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

Frank van Leth, Praphan Phanuphak, Kiat Ruxrungtham et al. · The Lancet · 2004 · 683 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Proposed World-Health-Organization Staging System for Hiv-Infection and Disease - Preliminary Testing by An International Collaborative Cross-Sectional Study

Pedro Cahn, DA Cooper, B. Tindall et al. · AIDS · 1992 · 89 citations

Public Health, Health Sciences, Hiv Control +11

Discontinuation of Nevirapine Because of Hypersensitivity Reactions in Patients with Prior Treatment Experience, Compared with Treatment-Naive Patients: The ATHENA Cohort Study

F. W. N. M. Wit, A Kesselring, Luuk Gras et al. · Clinical Infectious Diseases · 2008 · 75 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmacotherapy +15

The impact of the M184V substitution in HIV‐1 reverse transcriptase on treatment response

Veronica Miller, Thomas Stark, AE Loeliger et al. · HIV Medicine · 2002 · 66 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Greater and more rapid depletion of mitochondrial DNA in blood of patients treated with dual (zidovudine+didanosine or zidovudine+zalcitabine) vs. single (zidovudine) nucleoside reverse transcriptase inhibitors

Peter Reiss, Miriam Casula, Anthony de Ronde et al. · HIV Medicine · 2004 · 61 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17